The first procedure in the world designed to treat a patient using a bioengineered external liver was recently performed by a team at Intermountain Medical Center.

An FDA study of 110 melatonin supplements marketed for children found doses ranged from 0 to 667 percent of the amount on the ...

Discover how 3D printing of body parts is transforming healthcare, from custom prosthetics to bioprinted organs.

Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.

United Therapeutics Corporation (NASDAQ: UTHR) is one of the most undervalued US stocks according to analysts. On June 24, ...

United Therapeutics Corporation made $24.64 a share (GAAP) on $2.88 billion in FY2024. The current analyst firm consensus has profits increasing to $27.68 a share as sales climb to $3.22 billion ...

United Therapeutics UTHR shares soared 3.5% in the last trading session to close at $286.14. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

United Therapeutics had a net margin of 40.31% and a return on equity of 19.22%. The firm had revenue of $794.40 million for the quarter, compared to analyst estimates of $726.82 million.

A high-level overview of United Therapeutics Corporation (UTHR) stock. View (UTHR) real-time stock price, chart, news, analysis, analyst reviews and more.

Following these transactions, Mahon holds 36,781 shares of United Therapeutics common stock. The sales were executed under a pre-arranged 10b5-1 trading plan, which was established on December 24 ...

HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies ...